Fund Evaluator:
Lord Abbett Health Care F (LHCFX)
Follow This Fund
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Fund Details
Lord Abbett Health Care F Overview
Lord Abbett Health Care F (LHCFX) is an actively managed Sector Equity Health fund. Lord Abbett launched the fund in 2019.
The investment seeks long-term capital appreciation. Under normal conditions, the fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity and equity-related securities of health care-related companies. The Advisor considers health care-related companies to be those companies that operate in, or are related to, the major subsectors of the health care sector, including pharmaceuticals, biotechnology, health care technology, life sciences tools and services, health care equipment and supplies, and health care providers and services.
About Lord Abbett Health Care F (LHCFX)
There are 4 members of the management team with an average tenure of 6.36 years: Matthew DeCicco (2019), Devesh Karandikar (2019), Heidi Lawrence (2021), Samantha Shevins (2021). Management tenure is more important for actively managed funds than passive index funds.
The fund has 2 primary benchmarks: MSCI ACWI NR USD index with a weighting of 100% and MSCI ACWI/Health Care NR USD index with a weighting of 100%. Lord Abbett Health Care F has 54 securities in its portfolio. The top 10 holdings constitute 43.0% of the fund’s assets. The fund meets the SEC requirement of being classified as a diversified fund. The fund is not considered to have an ESG focus with its investment selection and management.
Lord Abbett Health Care F is part of the Equity global asset class and is within the Sector Equity fund group. Lord Abbett Health Care F has 19.1% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 80.9%. There is 19.1% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Lord Abbett Health Care F has 0.0% of the portfolio in cash.
Assets Under Management
The fund has $137 million in total assets, which is below the $884 million average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
LHCFX Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Lord Abbett Health Care F expense ratio is above average compared to funds in the Health category. Lord Abbett Health Care F has an expense ratio of 0.78%, which is 36% lower than its category average, making the fund expense ratio grade a B. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Lord Abbett Health Care F has a portfolio turnover rate of 91%, indicating that holds its assets around 0.0 years. By way of comparison, the average portfolio turnover is 61% for the Health category.
Recently, in the month of July 2026, Lord Abbett Health Care F returned -1.3%, which earned it a grade of D, as the Health category had an average return of -0.4%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all funds in that category.
Lord Abbett Health Care F has a trailing yield of 0.24%, which is below the 0.39% category average. The fund normally distributes its income annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Lord Abbett Health Care F Grades
Year to date, the fund has returned 3.3%, 3.8 percentage points worse than the category, which translates into a grade of D. The fund has returned 28.9% over the past year (grade of C), 9.3% over the past three years (grade of C) and 3.8% per year over the past five years (grade of C).
For more mutual fund grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Lord Abbett Health Care F, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
LHCFX Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| LHCFX Return (NAV) | -1.3% | 8.5% | 28.9% | 9.3% | 3.8% | na |
| LHCFX Grade | D | D | C | C | C | na |
| +/- Category | -0.9% | -2.2% | -5.0% | -1.4% | -1.2% | na |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| LHCFX Tax Cost Ratio | na | na | 0.1% | 0.1% | 0.4% | na |
LHCFX Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| LHCFX Return (NAV) | 3.3% | 18.0% | 7.5% | 3.2% | -11.8% | 8.5% | 37.4% | na | na | na | na |
| LHCFX Grade | D | B | A | D | D | C | A | na | na | na | na |
| +/- Category | -3.8% | -2.6% | 5.0% | -2.4% | -2.4% | -0.2% | 12.9% | na | na | na | na |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 16.7% |
| Total Risk Index: | 1.36 - High |
| Category Risk Index: | 1.04 - Above Average |
| Category Risk Grade: | D (79% Rank) |
| Beta: | 0.75 |
| R-Squared: | 32% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Mid-Cap Growth |
| Bond Investment Style: | na |
| Yield: | 0.2% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | |
| Total Assets: | $8 Mil |
| Fund Total Assets: | $ 0 Mil |
| Share Class Type: | Other |
| Portfolio Turnover: | 91% |
Management Team
| Number of Managers: 4 | |||
| Longest Tenure: 7.5 years | |||
| Average Tenure: 6.4 years | |||
| Managers (Year): DeCicco Matthew (2019), Karandikar Devesh (2019), Lawrence Heidi (2021), Shevins Samantha (2021) | |||
Portfolio Composition (as of 5/31/26)
| # of Holdings: | 54 |
| % in Top 10 Holdings: | 43.0% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 19.1% |
Portfolio Allocation |
|
| Domestic Stock: | 80.9% |
| Foreign Stock: | 19.1% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.0% |
Purchase Information
| Fund Family: | Lord Abbett |
| Phone Number: | 888-522-2388 |
| Website: | www.lordabbett.com |
| Status: | Open |
| Inception Date: | July 31, 2019 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.10% |
Expenses and Fees | |
| Expense Ratio (%): | 0.78% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Lord Abbett Health Care R6 |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
